CoChat

The effects of probiotic and synbiotic supplementation on inflammatory markers among patients with diabetes: A systematic review and meta-analysis of randomized controlled trials

Tabrizi, Reza, Ostadmohammadi, Vahidreza, Lankarani, Kamran B., Akbari, Maryam, Akbari, Hamideh, Vakili, Sina, Shokrpour, Maryam, Kolahdooz, Fariba, Rouhi, Vajihe, Asemi, Zatollah · 2019 · European Journal of Pharmacology
Cited by 63

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

This systematic review and meta‐analysis of randomized controlled trials (RCTs) was performed to evaluate the effect of probiotic and symbiotic supplementation on inflammatory markers among patients with diabetes. Clinical trials were searched using Cochrane Library, EMBASE, PubMed, and Web of Science online databases for relevant trials published until April 2018. Two independent investigators evaluated study eligibility, extracted data, and assessed risk of bias of included clinical trials. Cochran's Q test and I‐square (I2) statistic were used to detect heterogeneity among the included. Data were pooled by using the random‐effect model and standardized mean difference (SMD) was considered as the summary effect size. From 986 originally identified publications 18 clinical trials with a total of 1337 patients were included. Findings showed that probiotic and synbiotic supplementation among patients with diabetes significantly decreased tumor necrosis factor‐&agr; (TNF‐&agr;) (SMD = −2.99; 95% CI, −4.77, −1.20; P = 0.001; I2: 96.3), and C‐reactive protein (CRP) (SMD = −0.87; 95% CI, −1.27, −0.48; P < 0.001; I2: 90.2); while significantly increased nitric oxide (NO) concentrations (SMD = 1.49; 95% CI, 0.81, 2.16; P < 0.001; I2: 92.1). There were no effects of probiotic and synbiotic supplementation on interleukin‐6 (IL‐6) levels (SMD = −0.65; 95% CI, −1.88, 0.59; P = 0.30; I2: 94.7). In summary, the current meta‐analysis demonstrated probiotic and synbiotic supplementation among patients with diabetes significantly decreased CRP and TNF‐&agr;, and increased NO levels, but did not affect IL‐6 levels.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejphar.2019.04.003

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 63

Metadata

Authors
Tabrizi, R., Ostadmohammadi, V., Lankarani, K. B., Akbari, M., Akbari, H., Vakili, S., Shokrpour, M., Kolahdooz, F., Rouhi, V., & Asemi, Z.
Venue
European Journal of Pharmacology
Publisher
Elsevier BV
Published
2019-06
Volume
852
Pages
254-264
ISSN
0014-2999 (ISSN-L)
OpenAlex
W2926434199
Cited by
63
References
10
FWCI
1.77
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The effects of probiotic and synbiotic supplementation on inflammatory markers among patients with diabetes: A systematic review and meta-analysis of randomized controlled trials. https://app.cochat.ai/papers/10.1016/j.ejphar.2019.04.003
The paper
Tabrizi, R., Ostadmohammadi, V., Lankarani, K. B., Akbari, M., Akbari, H., Vakili, S., Shokrpour, M., Kolahdooz, F., Rouhi, V., & Asemi, Z. (2019). The effects of probiotic and synbiotic supplementation on inflammatory markers among patients with diabetes: A systematic review and meta-analysis of randomized controlled trials. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2019.04.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.